HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lipoprotein composition in HNF1A-MODY: differentiating between HNF1A-MODY and type 2 diabetes.

AbstractINTRODUCTION:
The young-onset diabetes seen in HNF1A-MODY is often misdiagnosed as Type 2 diabetes. Type 2 diabetes, unlike HNF1A-MODY, is associated with insulin resistance and a characteristic dyslipidaemia. We aimed to compare the lipid profiles in HNF1A-MODY, Type 2 diabetes and control subjects and to determine if lipids can be used to aid the differential diagnosis of diabetes sub-type.
METHODS:
1) 14 subjects in each group (HNF1A-MODY, Type 2 diabetes and controls) were matched for gender and BMI. Fasting lipid profiles and HDL lipid constituents were compared in the 3 groups. 2) HDL-cholesterol was assessed in a further 267 patients with HNF1A-MODY and 297 patients with a diagnosis of Type 2 diabetes to determine its discriminative value.
RESULTS:
1) In HNF1A-MODY subjects, plasma-triglycerides were lower (1.36 vs. 1.93 mmol/l, p = 0.07) and plasma-HDL-cholesterol was higher than in subjects with Type 2 diabetes (1.47 vs. 1.15 mmol/l, p = 0.0008), but was similar to controls. Furthermore, in the isolated HDL; HDL-phospholipid and HDL-cholesterol ester content were higher in HNF1A-MODY, than in Type 2 diabetes (1.59 vs. 1.33 mmol/L, p = 0.04 and 1.10 vs. 0.83 mmol/L, p = 0.019, respectively), but were similar to controls (1.59 vs. 1.45 mmol/L, p = 0.35 and 1.10 vs. 1.21 mmol/L, p = 0.19, respectively). 2) A plasma-HDL-cholesterol > 1.12 mmol/L was 75% sensitive and 64% specific (ROC AUC = 0.76) at discriminating HNF1A-MODY from Type 2 diabetes.
CONCLUSION:
The plasma-lipid profiles of HNF1A-MODY and the lipid constituents of HDL are similar to non-diabetic controls. However, HDL-cholesterol was higher in HNF1A-MODY than in Type 2 diabetes and could be used as a biomarker to aid in the identification of patients with HNF1A-MODY.
AuthorsTim J McDonald, Jane McEneny, Ewan R Pearson, Gaya Thanabalasingham, Magdalena Szopa, Beverley M Shields, Sian Ellard, Katharine R Owen, Maciej T Malecki, Andrew T Hattersley, Ian S Young
JournalClinica chimica acta; international journal of clinical chemistry (Clin Chim Acta) Vol. 413 Issue 9-10 Pg. 927-32 (May 18 2012) ISSN: 1873-3492 [Electronic] Netherlands
PMID22360925 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier B.V. All rights reserved.
Chemical References
  • Biomarkers
  • Cholesterol, HDL
  • Cholesterol, LDL
  • HNF1A protein, human
  • Hepatocyte Nuclear Factor 1-alpha
  • Lipoproteins
  • Triglycerides
Topics
  • Adult
  • Aged
  • Biomarkers (blood)
  • Case-Control Studies
  • Cholesterol, HDL (blood)
  • Cholesterol, LDL (blood)
  • Diabetes Mellitus, Type 2 (blood, diagnosis)
  • Female
  • Hepatocyte Nuclear Factor 1-alpha (blood)
  • Humans
  • Lipoproteins (blood)
  • Male
  • Middle Aged
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: